Boston Angel Investors →
Founding Director, Massachusetts Technology Transfer Center
Managing Director, D.E. Shaw and Co., L.P.
VP of Venture Capital, Pfizer Inc.
Professor of Systems Biology, Columbia University
CEO and Co-Founder, Tamr
CEO and Fund Manager, Renaissance Venture Capital Fund
Co-Founder and CEO, DNAnexus
September 30, 2015 ·
October 30, 2015 ·
Keryx is developing a drug to treat kidney dialysis patients.
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin and beyond.
© 2007-2015, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.